Company Filing History:
Years Active: 2011
Title: Alex Brown - Innovator in Recombinant Technology
Introduction
Alex Brown is a notable inventor based in Bucks, GB. He has made significant contributions to the field of recombinant technology, particularly in the development of novel therapeutic compounds. His work focuses on creating purified recombinant αβ-adhesion receptors that have the potential to revolutionize therapeutic screening processes.
Latest Patents
Alex Brown holds 1 patent related to his invention of a purified recombinant αβ-adhesion receptor. This invention demonstrates unimpaired ligand binding activity and outlines a process for preparing a soluble, non-membrane bound receptor using recombinant techniques with a baculovirus-insect cell expression system. The soluble receptor serves as an effective screening tool for new therapeutic compounds that may inhibit the natural αβ-adhesion receptor. This innovation allows for the rapid and safe discovery of therapeutic compounds, such as RGD peptides or non-peptidic compounds that mimic natural ligand epitopes.
Career Highlights
Alex Brown is currently employed at Merck Patent GmbH, where he continues to advance his research and development efforts. His work has positioned him as a key figure in the field of biotechnology, particularly in the area of receptor technology.
Collaborations
Throughout his career, Alex has collaborated with esteemed colleagues, including Simon Lawrence Goodman and Beate Diefenbach. These partnerships have further enhanced the impact of his research and innovations.
Conclusion
Alex Brown's contributions to recombinant technology and therapeutic development highlight his role as an influential inventor. His innovative approaches have the potential to significantly impact the field of medicine and therapeutic discovery.